
Aired: Tue, Oct 6th 2026, 5:00 PM
In this LabX Before You Buy Q&A session, experts from INFORS HT discuss the considerations scientists and engineers should weigh when comparing modern bench-top bioreactors. The conversation moves beyond data sheets, into the questions that tend to surface six months into a project. Does control transparency hold up when scale-up encounters the unexpected? Does the level of automation genuinely reduce hands-on time in your workflow, or quietly add complexity? Is data accessibility built around how process development teams work today, including for technology transfer and Quality by Design (QbD) initiatives? And when reproducibility breaks down across users or sites, where does the answer lie? Is it in the hardware, the protocol, or in the depth of application support behind the platform?
Attendees will leave with a practical framework for assessing whether a bioreactor, and the team behind it, is equipped to support current development needs while remaining flexible enough to meet whatever comes next.
Key Learning Objectives:
Speakers:
Lea Wagner, Product Manager, INFORS HT
Sven Kleinschiphorst, Product Manager, INFORS HT
Host:
Damon Anderson, PhD, Technology Editor at LabX

Create an account now for exclusive benefits, personalized recommendations, and seamless order tracking. Elevate your lab experience today!